Related Experiment Video
Updated: Aug 12, 2026

08:55
Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats
Published on: April 15, 2016
Cavernous haemangioma with Kasabach-Merritt syndrome: treatment with alpha-interferon
J J Ettlinger1, P J Fleming, H S Joffe
1Department of Neonatal and Intensive Care Medicine, Royal Hospital for Sick Children, Bristol, England.
Journal of the Royal Society of Medicine
|January 1, 1996
Insights
Serious complications like Kasabach-Merritt syndrome can arise in infants with haemangioma. This report details the successful management of an infant experiencing this rare syndrome.
Area of Science:
- Pediatric Oncology
- Vascular Malformations
Background:
- Infantile haemangiomas are common benign vascular tumors.
- A subset of patients develop life-threatening complications.
- Kasabach-Merritt syndrome is a rare but severe complication characterized by thrombocytopenia and coagulopathy.
Abstract:
A small number of patients with haemangioma need treatment for serious complications such as Kasabach-Merritt syndrome, cardiac failure and obstruction of the airway. We report on the management of an infant with Kasabach-Merritt syndrome.

